Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2016 by Christine and Malay, Ensemble Labs is an angel investment fund based in the United States. The firm focuses on early-stage investments in healthcare technology, managing a portfolio of 24 companies. They invest their own capital and emphasize supporting impactful projects and founders.
Ensemble Labs invests in pre-seed to seed+ stage companies primarily within healthcare, digital health, and AI sectors. They typically provide support in company-building, product development, go-to-market strategies, and networking introductions. Check sizes are not specified, but the firm is dedicated to early-stage ventures.
Notable companies in Ensemble Labs' portfolio include Doctor on Demand (acquired in 2021), Natalist (acquired in 2021), and Sitka (acquired in 2023). Other significant investments include Benchling, Candid Health, and Omada Health.
Submit your pitch through their website's contact form for consideration.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.